172 related articles for article (PubMed ID: 34813861)
21. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?
Marchegiani G; Andrianello S; Perri G; Secchettin E; Maggino L; Malleo G; Bassi C; Salvia R
HPB (Oxford); 2018 May; 20(5):411-417. PubMed ID: 29191689
[TBL] [Abstract][Full Text] [Related]
22. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
[TBL] [Abstract][Full Text] [Related]
23. Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis.
Choi SH; Park SH; Kim KW; Lee JY; Lee SS
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1509-1520.e4. PubMed ID: 28342950
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of small solid pancreatic lesions.
Dietrich CF; Sahai AV; D'Onofrio M; Will U; Arcidiacono PG; Petrone MC; Hocke M; Braden B; Burmester E; Möller K; Săftoiu A; Ignee A; Cui XW; Iordache S; Potthoff A; Iglesias-Garcia J; Fusaroli P; Dong Y; Jenssen C
Gastrointest Endosc; 2016 Dec; 84(6):933-940. PubMed ID: 27155592
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
Konings IC; Harinck F; Kuenen MA; Sidharta GN; Kieffer JM; Aalfs CM; Poley JW; Smets EM; Wagner A; van Rens A; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ; Bleiker EM;
Fam Cancer; 2017 Jan; 16(1):143-151. PubMed ID: 27629874
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
27. Incidence and Mortality Rates of Second Pancreatic Cancer Among Survivors of Digestive Cancers: A Nationwide Population-Based Study.
Ahn HS; Kang TU; Swan H; Kang MJ; Kim N; Kim HJ; Park SM
Pancreas; 2019 Mar; 48(3):412-419. PubMed ID: 30768577
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
Dudley B; Brand RE
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic Cysts Greater Than 1 cm Are Associated With an Increased Risk for Developing Pancreatic Cancer in Individuals From Pancreatic-Cancer Prone Kindreds Undergoing Surveillance.
Aijazi M; Fasanella KE; McGrath K; Smith LM; Singhi AD; Brand RE
Pancreas; 2024 Apr; 53(4):e350-e356. PubMed ID: 38518061
[TBL] [Abstract][Full Text] [Related]
31. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
[TBL] [Abstract][Full Text] [Related]
32. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
Ishida J; Toyama H; Matsumoto I; Asari S; Goto T; Terai S; Nanno Y; Yamashita A; Mizumoto T; Ueda Y; Kido M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2016; 16(4):615-20. PubMed ID: 27237099
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.
Paiella S; Capurso G; Carrara S; Secchettin E; Casciani F; Frigerio I; Zerbi A; Archibugi L; Bonifacio C; Malleo G; Cavestro GM; Barile M; Larghi A; Assisi D; Fantin A; Milanetto AC; Fabbri C; Casadei R; Donato G; Sassatelli R; De Marchi G; Di Matteo FM; Arcangeli V; Panzuto F; Puzzono M; Dal Buono A; Pezzilli R; Salvia R; Rizzatti G; Casadio M; Franco M; Butturini G; Pasquali C; Coluccio C; Ricci C; Cicchese N; Sereni G; de Pretis N; Stigliano S; Rudnas B; Marasco M; Lionetto G; Arcidiacono PG; Terrin M; Crovetto A; Mannucci A; Laghi L; Bassi C; Falconi M
Am J Gastroenterol; 2024 Apr; 119(4):739-747. PubMed ID: 37787643
[TBL] [Abstract][Full Text] [Related]
34. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
35. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
Brunner M; Weber GF; Kersting S; Grützmann R
Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
[TBL] [Abstract][Full Text] [Related]
36. Postoperative surveillance of pancreatic cancer patients.
Daamen LA; Groot VP; Intven MPW; Besselink MG; Busch OR; Koerkamp BG; Mohammad NH; Hermans JJ; van Laarhoven HWM; Nuyttens JJ; Wilmink JW; van Santvoort HC; Molenaar IQ; Stommel MWJ;
Eur J Surg Oncol; 2019 Oct; 45(10):1770-1777. PubMed ID: 31204168
[TBL] [Abstract][Full Text] [Related]
37. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis.
Kogekar N; Diaz KE; Weinberg AD; Lucas AL
Pancreatology; 2020 Dec; 20(8):1739-1746. PubMed ID: 33077384
[TBL] [Abstract][Full Text] [Related]
38. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.
Dbouk M; Katona BW; Brand RE; Chak A; Syngal S; Farrell JJ; Kastrinos F; Stoffel EM; Blackford AL; Rustgi AK; Dudley B; Lee LS; Chhoda A; Kwon R; Ginsberg GG; Klein AP; Kamel I; Hruban RH; He J; Shin EJ; Lennon AM; Canto MI; Goggins M
J Clin Oncol; 2022 Oct; 40(28):3257-3266. PubMed ID: 35704792
[TBL] [Abstract][Full Text] [Related]
39. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
40. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
